$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The latest information on the domestic launch progress and market price of obeticholic acid in 2024
2026-02-01 22:25:32
Check Details
Brief description of ibrutinib/ibrutinib medication guidelines
2026-02-01 22:25:32
Check Details
Detailed explanation of the usage and precautions of Incepta version of ibrutinib/ibrutinib
2026-02-01 22:25:32
Check Details
What are the serious side effects that may occur when taking ibrutinib/ibrutinib, and are they likely to occur?
2026-02-01 22:25:32
Check Details
What to do after cabozantinib resistance?
2026-02-01 22:25:32
Check Details
Analysis of the main role of cabozantinib as a targeted drug
2026-02-01 22:25:32
Check Details
Is cabozantinib effective in small cell lung cancer? Can it be cured?
2026-02-01 22:25:32
Check Details
Dosing Guidelines for Cabozantinib in Combination with PD-1
2026-02-01 22:25:32
Check Details
What are the side effects of afatinib combined with cabozantinib?
2026-02-01 22:25:32
Check Details
Comparison of the efficacy of Iressa and cabozantinib: Which one is better?
2026-02-01 22:25:32
Check Details
Is cabozantinib effective in treating liver cancer?
2026-02-01 22:25:32
Check Details
Is temozolomide suitable for brainstem glioma?
2026-02-01 22:25:32
Check Details
1
2
...
962
963
964
965
966
967
968
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
2
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
3
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
4
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
5
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
6
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
7
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
8
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
9
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
10
Complete Guide to Dosage and Dose Adjustment of Entrectinib
11
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
12
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment